187 related articles for article (PubMed ID: 35686702)
21. ePTFE-TIPS vs repetitive LVP plus albumin for the treatment of refractory ascites in patients with cirrhosis.
Bucsics T; Hoffman S; Grünberger J; Schoder M; Matzek W; Stadlmann A; Mandorfer M; Schwabl P; Ferlitsch A; Peck-Radosavljevic M; Trauner M; Karner J; Karnel F; Reiberger T
Liver Int; 2018 Jun; 38(6):1036-1044. PubMed ID: 29091351
[TBL] [Abstract][Full Text] [Related]
22. Current concepts in the management of refractory cirrhotic ascites.
Oguntona SA; Alebiosu CO
Niger J Med; 2006; 15(3):197-202. PubMed ID: 17111742
[TBL] [Abstract][Full Text] [Related]
23. Current management of refractory ascites in patients with cirrhosis.
Zhao R; Lu J; Shi Y; Zhao H; Xu K; Sheng J
J Int Med Res; 2018 Mar; 46(3):1138-1145. PubMed ID: 29210304
[TBL] [Abstract][Full Text] [Related]
24. Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial. French Group of Clinicians and a Group of Biologists.
Lebrec D; Giuily N; Hadengue A; Vilgrain V; Moreau R; Poynard T; Gadano A; Lassen C; Benhamou JP; Erlinger S
J Hepatol; 1996 Aug; 25(2):135-44. PubMed ID: 8878773
[TBL] [Abstract][Full Text] [Related]
25. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
[TBL] [Abstract][Full Text] [Related]
26. Feasibility and Procedural Safety of alfapump System Implantation by IR: Experience from the MOSAIC Study, a Multicenter, Open-Label Prospective Study in Cirrhotic Patients with Refractory Ascites.
Bendel EC; Sniderman K; Shaw C; Frederick RT; Wong F; Sanyal A; Asrani SK; Kamath PS; Capel J; Haskal ZJ
J Vasc Interv Radiol; 2020 Aug; 31(8):1256-1262.e3. PubMed ID: 32654961
[TBL] [Abstract][Full Text] [Related]
27. Management of the Adult Patient with Cirrhosis Complicated by Ascites.
Nobbe AM; McCurdy HM
Crit Care Nurs Clin North Am; 2022 Sep; 34(3):311-320. PubMed ID: 36049850
[TBL] [Abstract][Full Text] [Related]
28. Transjugular intrahepatic portosystemic shunt versus paracentesis plus albumin in patients with refractory ascites who have good hepatic and renal function: a prospective randomized trial.
Narahara Y; Kanazawa H; Fukuda T; Matsushita Y; Harimoto H; Kidokoro H; Katakura T; Atsukawa M; Taki Y; Kimura Y; Nakatsuka K; Sakamoto C
J Gastroenterol; 2011 Jan; 46(1):78-85. PubMed ID: 20632194
[TBL] [Abstract][Full Text] [Related]
29. TIPS improves liver transplantation-free survival in cirrhotic patients with refractory ascites: an updated meta-analysis.
Bai M; Qi XS; Yang ZP; Yang M; Fan DM; Han GH
World J Gastroenterol; 2014 Mar; 20(10):2704-14. PubMed ID: 24627607
[TBL] [Abstract][Full Text] [Related]
30. A meta-analysis of transjugular intrahepatic portosystemic shunt versus paracentesis for refractory ascites.
Albillos A; Bañares R; González M; Catalina MV; Molinero LM
J Hepatol; 2005 Dec; 43(6):990-6. PubMed ID: 16139922
[TBL] [Abstract][Full Text] [Related]
31. TIPS versus paracentesis for cirrhotic patients with refractory ascites.
Saab S; Nieto JM; Lewis SK; Runyon BA
Cochrane Database Syst Rev; 2006 Oct; 2006(4):CD004889. PubMed ID: 17054221
[TBL] [Abstract][Full Text] [Related]
32. Alfapump
Weil-Verhoeven D; Di Martino V; Stirnimann G; Cervoni JP; Nguyen-Khac E; Thévenot T
World J Hepatol; 2022 Jul; 14(7):1344-1356. PubMed ID: 36158913
[TBL] [Abstract][Full Text] [Related]
33. TIPS versus paracentesis for cirrhotic patients with refractory ascites.
Saab S; Nieto JM; Ly D; Runyon BA
Cochrane Database Syst Rev; 2004; (3):CD004889. PubMed ID: 15266548
[TBL] [Abstract][Full Text] [Related]
34. Management of Severe and Refractory Ascites.
Larrue H; Vinel JP; Bureau C
Clin Liver Dis; 2021 May; 25(2):431-440. PubMed ID: 33838859
[TBL] [Abstract][Full Text] [Related]
35. Automated low-flow ascites pump for the treatment of cirrhotic patients with refractory ascites.
Stirnimann G; Banz V; Storni F; De Gottardi A
Therap Adv Gastroenterol; 2017 Feb; 10(2):283-292. PubMed ID: 28203285
[TBL] [Abstract][Full Text] [Related]
36. Editorial: alfapump-an alternative to large-volume paracentesis for patients with refractory ascites?
Macdonald S; Jalan R
Aliment Pharmacol Ther; 2018 Jan; 47(1):139-140. PubMed ID: 29226396
[No Abstract] [Full Text] [Related]
37. TIPS for management of refractory ascites: response and survival are both unpredictable.
Thuluvath PJ; Bal JS; Mitchell S; Lund G; Venbrux A
Dig Dis Sci; 2003 Mar; 48(3):542-50. PubMed ID: 12757168
[TBL] [Abstract][Full Text] [Related]
38. Daily Low-Volume Paracentesis and Clinical Complications in Patients With Refractory Ascites.
Tergast TL; Griemsmann M; Stockhoff L; Port K; Heidrich B; Cornberg M; Wedemeyer H; Lenzen H; Richter N; Jaeckel E; Maasoumy B
JAMA Netw Open; 2023 Jul; 6(7):e2322048. PubMed ID: 37410459
[TBL] [Abstract][Full Text] [Related]
39. Management of refractory ascites and hepatorenal syndrome.
Chutaputti A
J Gastroenterol Hepatol; 2002 Apr; 17(4):456-61. PubMed ID: 11982727
[TBL] [Abstract][Full Text] [Related]
40. The transjugular intrahepatic portosystemic shunt for the management of cirrhotic refractory ascites.
Garcia-Tsao G
Nat Clin Pract Gastroenterol Hepatol; 2006 Jul; 3(7):380-9. PubMed ID: 16819501
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
